These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34319985)

  • 1. Targeting Mycobacterium tuberculosis response to environmental cues for the development of effective antitubercular drugs.
    Lavin RC; Johnson C; Ahn YM; Kremiller KM; Sherwood M; Patel JS; Pan Y; Russo R; MacGilvary NJ; Giacalone D; Kevorkian YL; Zimmerman MD; Glickman JF; Freundlich JS; Tan S
    PLoS Biol; 2021 Jul; 19(7):e3001355. PubMed ID: 34319985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis responds to chloride and pH as synergistic cues to the immune status of its host cell.
    Tan S; Sukumar N; Abramovitch RB; Parish T; Russell DG
    PLoS Pathog; 2013; 9(4):e1003282. PubMed ID: 23592993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment.
    VanderVen BC; Fahey RJ; Lee W; Liu Y; Abramovitch RB; Memmott C; Crowe AM; Eltis LD; Perola E; Deininger DD; Wang T; Locher CP; Russell DG
    PLoS Pathog; 2015 Feb; 11(2):e1004679. PubMed ID: 25675247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting
    Dechow SJ; Abramovitch RB
    Microbiology (Reading); 2024 May; 170(5):. PubMed ID: 38717801
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycobacterium tuberculosis response to cholesterol is integrated with environmental pH and potassium levels via a lipid metabolism regulator.
    Chen Y; MacGilvary NJ; Tan S
    PLoS Genet; 2024 Jan; 20(1):e1011143. PubMed ID: 38266039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
    Devi PB; Sridevi JP; Kakan SS; Saxena S; Jeankumar VU; Soni V; Anantaraju HS; Yogeeswari P; Sriram D
    Tuberculosis (Edinb); 2015 Dec; 95(6):786-794. PubMed ID: 26299907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors.
    Sahu NU; Singh V; Ferraris DM; Rizzi M; Kharkar PS
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1714-1718. PubMed ID: 29699922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of
    Chen Z; Kong X; Ma Q; Chen J; Zeng Y; Liu H; Wang X; Lu S
    Front Immunol; 2024; 15():1402024. PubMed ID: 38873598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium response and homeostasis in Mycobacterium tuberculosis modulates environmental adaptation and is important for host colonization.
    MacGilvary NJ; Kevorkian YL; Tan S
    PLoS Pathog; 2019 Feb; 15(2):e1007591. PubMed ID: 30716121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS
    Bioorg Med Chem; 2017 Nov; 25(21):6039-6048. PubMed ID: 28993106
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Chen Y; MacGilvary NJ; Tan S
    bioRxiv; 2023 Aug; ():. PubMed ID: 37662244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole cell screen for inhibitors of pH homeostasis in Mycobacterium tuberculosis.
    Darby CM; Ingólfsson HI; Jiang X; Shen C; Sun M; Zhao N; Burns K; Liu G; Ehrt S; Warren JD; Andersen OS; Brickner SJ; Nathan C
    PLoS One; 2013; 8(7):e68942. PubMed ID: 23935911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD
    Wang X; Ahn YM; Lentscher AG; Lister JS; Brothers RC; Kneen MM; Gerratana B; Boshoff HI; Dowd CS
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4426-4430. PubMed ID: 28827112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
    Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Nov; 22(21):6134-45. PubMed ID: 25282650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of SQ609 as a lead compound from a library of dipiperidines.
    Bogatcheva E; Hanrahan C; Nikonenko B; de los Santos G; Reddy V; Chen P; Barbosa F; Einck L; Nacy C; Protopopova M
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5353-7. PubMed ID: 21807506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More than cholesterol catabolism: regulatory vulnerabilities in Mycobacterium tuberculosis.
    Bonds AC; Sampson NS
    Curr Opin Chem Biol; 2018 Jun; 44():39-46. PubMed ID: 29906645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages.
    Sorrentino F; Gonzalez del Rio R; Zheng X; Presa Matilla J; Torres Gomez P; Martinez Hoyos M; Perez Herran ME; Mendoza Losana A; Av-Gay Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):640-5. PubMed ID: 26503663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antimycobacterial activity of 4-[5-(substituted phenyl)-4, 5-dihydro-3-isoxazolyl]-2-methylphenols.
    Shaharyar M; Ali MA; Bakht MA; Murugan V
    J Enzyme Inhib Med Chem; 2008 Jun; 23(3):432-6. PubMed ID: 18569351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.